MedPath

Respiralab S.A.

πŸ‡ͺπŸ‡¨Ecuador
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Phototherapy in the Treatment of Loss of Smell Post Acute Infection of Coronavirus 19

Not Applicable
Conditions
Smell Disorders
Interventions
Combination Product: Phototherapy
Combination Product: OT+Corticosteroids
First Posted Date
2022-01-04
Last Posted Date
2022-01-04
Lead Sponsor
Respiralab
Target Recruit Count
40
Registration Number
NCT05177445
Locations
πŸ‡ͺπŸ‡¨

Respiralab Research Group, Guayaquil, Guayas, Ecuador

OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association

Completed
Conditions
Sleep Apnea, Obstructive
First Posted Date
2022-01-03
Last Posted Date
2022-01-03
Lead Sponsor
Respiralab
Target Recruit Count
340
Registration Number
NCT05175287
Locations
πŸ‡ͺπŸ‡¨

Respiralab Research Group, Guayaquil, Guayas, Ecuador

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

Completed
Conditions
Adverse Drug Event
Interventions
Biological: Pfizer-BioNTech COVID-19 vaccine
First Posted Date
2021-11-09
Last Posted Date
2021-11-09
Lead Sponsor
Respiralab
Target Recruit Count
1291
Registration Number
NCT05113472
Locations
πŸ‡ͺπŸ‡¨

Universidad Espiritu Santo, Samborondon, Ecuador

Β© Copyright 2025. All Rights Reserved by MedPath